NYSE · Medical - Specialties

SI (SI) Stock

$22.45 +7.08% NYSE: SI Healthcare

Valuation

MetricValue
Price$22.45
Market Cap$465.47M
P/E Ratio-28.65
P/B Ratio1.99
P/S Ratio5.73
EPS (TTM)$-0.52
52-Week High$22.79
52-Week Low$10.92
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-25.81%
ROA-23.53%
ROCE-16.77%
Gross Margin-57.45%
Operating Margin-55.32%
Net Margin-81.78%
Debt/Equity0.11
Current Ratio-19.62

Annual Financials (USD)

Metric202320242025
Revenue$19.0M$32.0M$47.0M
Operating Profit$-11.0M$-15.0M$-26.0M
Net Profit$-13.0M$-16.0M$-40.0M
EPS$-0.63$-0.77$-0.52
Op Margin-56.4%-46.3%-55.6%

Balance Sheet (USD)

Metric202320242025
Total Assets$54.0M$43.0M$170.0M
Total Liabilities$94.0M$98.0M$15.0M
Cash$6.0M$6.0M$27.0M
Borrowings$14.0M$15.0M$15.0M

Latest News

Shoulder Innovations to Report Second Quarter 2026 Financial Results on August 6, 2026 PR Newswire · Jul 14, 2026 Shoulder Innovations Closes Up to $50 Million Credit Facility MT Newswires · Jun 29, 2026 Shoulder Innovations Announces Closing of up to $50 Million Credit Facility PR Newswire · Jun 29, 2026 Wall Street Analysts See a 51.79% Upside in Shoulder Innovations, Inc. (SI): Can the Stock Really Move This High? Zacks · Jun 3, 2026 Shoulder Innovations to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire · May 26, 2026

Cash Flow (USD)

Metric202320242025
Operating Cash Flow$-13.0M$-14.0M$-29.0M
Investing Cash Flow$-32.0M$10.0M$-103.0M
Financing Cash Flow$0$0$145.0M
Net Cash Flow$3.0M$0$21.0M
Free Cash Flow$-16.0M$-18.0M$-36.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-14.19%
Quick Ratio10.04
Interest Coverage—
Return 1Y—
Return 3Y—
Return 5Y—

Ownership

Institutional HolderSharesReport Date
FMR, LLC3,784,5522026-03-31
Blackrock Inc.556,0522026-03-31
Sectoral Asset Management, Inc.430,4072026-03-31
Vanguard Capital Management LLC413,4802026-03-31
Times Square Capital Management, LLC322,7642026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AARD $6.42 -4.04% -1.62 $140.50M 0.00%
ASMB $26.68 +0.87% -51.53 $424.02M 0.00%
ENTA $12.61 -0.94% -6.04 $366.68M 0.00%
EPRX $6.05 +4.13% -5.99 $202.55M 0.00%
INGN $6.49 +1.09% -8.00 $175.71M 0.00%

About SI

SI is led by CEO Alan J. Lane, employs 300 people, headquartered in US, publicly traded since 2025.

SI stock trades at $22.45 with a market capitalization of $465.47M. The stock is valued at a price-to-earnings (P/E) ratio of -28.65, price-to-book of 1.99, price-to-sales of 5.73. Over the past 52 weeks the stock has ranged between $10.92 and $22.79, and currently trades 1.5% below its 52-week high.

On profitability, SI generates a return on equity (ROE) of -25.81%, return on capital employed of -16.77%, an operating margin of -55.32%, a net profit margin of -81.78%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides